Invention Grant
- Patent Title: Morphic forms of 4-amino-7-(3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-methyl-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide and uses thereof
-
Application No.: US16645876Application Date: 2018-09-21
-
Publication No.: US11111264B2Publication Date: 2021-09-07
- Inventor: Roy W. Ware , Venkat Lakshmanan , Aaron Leigh Downey
- Applicant: Chimerix, Inc.
- Applicant Address: US NC Durham
- Assignee: Chimerix, Inc.
- Current Assignee: Chimerix, Inc.
- Current Assignee Address: US NC Durham
- Agency: Cooley LLP
- Agent Heidi A. Erlacher; Gabriel Magallanes
- International Application: PCT/US2018/052180 WO 20180921
- International Announcement: WO2019/060692 WO 20190328
- Main IPC: C07H19/14
- IPC: C07H19/14
![Morphic forms of 4-amino-7-(3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-methyl-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide and uses thereof](/abs-image/US/2021/09/07/US11111264B2/abs.jpg.150x150.jpg)
Abstract:
The present disclosure relates to crystalline morphic forms of 4-amino-7-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl)-2-methyl-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide. The morphic form can be a stable hemihydrate crystalline form.
Public/Granted literature
Information query
IPC分类: